Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. - Wikidata - awgldk - TriplyDB

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

http://www.wikidata.org/entity/Q34373447

about

MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling Tiny giants of gene regulation: experimental strategies for microRNA functional studies Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection MicroRNA expression in hepatitis C virus-related malignancies: A brief review MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics The Regulatory Role of MicroRNAs in EMT and Cancer Anti-miRs competitively inhibit microRNAs in Argonaute complexes MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.Short loop-targeting oligoribonucleotides antagonize Lin28 and enable pre-let-7 processing and suppression of cell growth in let-7-deficient cancer cells.Nonconventional chemical inhibitors of microRNA: therapeutic scope.A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications.Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.MicroRNA as tools and therapeutics in lung cancer Site-specific conjugation of drug-like fragments to an antimiR scaffold as a strategy to target miRNAs inside RISC.HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge.A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases.MiR-384 Regulates the Th17/Treg Ratio during Experimental Autoimmune Encephalomyelitis Pathogenesis.Epigenetic-based immune intervention for rheumatic diseases.Antiviral therapy for chronic hepatitis C in 2014.MicroRNA: potential biomarkers and therapeutic targets for allergic asthma?New treatments for chronic hepatitis C: an overview for paediatricians.Introduction of 2,6-Diaminopurines into Serinol Nucleic Acid Improves Anti-miRNA Performance.Therapeutic oligonucleotides with polyethylene glycol modifications.Advances, nuances, and potential pitfalls when exploiting the therapeutic potential of RNA interference.Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.Innate Immunity Post-Hematopoietic Stem Cell Transplantation: Focus on Epigenetics Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.Missing link between microRNA and prostate cancer.Exploiting microRNAs As Cancer Therapeutics.MicroRNAs in metabolism.

P2860

Q26740198-EAFD73C9-FD43-4E2B-B110-DD14EE0F92A2 Q26767339-E6AA00E3-8974-4B7F-B802-792F05B3580A Q26779128-95B29158-DCBF-41A7-87BE-2B66931AF3B2 Q26801181-9357E2D4-5FB8-4247-9F30-78FE46696DB7 Q26801487-BAD11F35-4703-4E88-9834-3FBD141E24CC Q26859021-55756E30-E7F7-4662-A7F0-ECC58A067356 Q27023295-0CB632EC-8E6F-414F-8761-6E1DC093A9A9 Q27026846-FEC2776D-BB56-4095-9823-01CB5B90FC2F Q28087258-45D4C13A-A33B-41F4-92DE-04D655E5CE9A Q28391426-151F3C56-B4C1-42D0-90ED-C8334FC2BE22 Q28540355-DD4BAE1A-9C66-4A91-9201-9483B716C0CD Q28551988-6D8AE1B3-160A-4F6A-9931-B2363C6DD347 Q33632091-94A305A2-E9DB-4877-8146-552840615BBC Q33915812-0DC6ADE3-473B-4A5C-A869-EF724DB13CEA Q35093800-DB8F370C-D2D1-4938-8B24-3C635D588757 Q35097923-A7E771F2-4F4D-4ED0-8E5E-577EAAA30CE2 Q35346350-23C98E2A-FFC4-4CB8-8FAA-B6F11A80F2F1 Q35476690-ECF7E6A9-05AE-4B24-91AC-12096D33FF88 Q35591371-B51439FF-41ED-4103-A3BE-8AC0F96E1DAB Q35619546-EAE51F40-A171-4DEC-A9A7-7700A18BE6EF Q35738706-068D81D9-18AD-4BF4-886B-FF425021EE09 Q35822837-700C8529-0868-4685-A644-B49C9F8E25DF Q36029524-788E9E26-761A-41E4-8892-A0B4C584F954 Q36299692-ABDE9AA8-E0C5-42D9-9005-39A5F66F9431 Q36482989-EB65F901-DB2D-438D-8D2C-5F8892745F68 Q37723415-E18D4925-78D1-4ADA-B3B8-0719FE7071DF Q38210478-C4CEBE50-CB81-4398-953C-B10724AAC5F2 Q38221090-5D246009-4A92-493F-BE3E-9925289F1740 Q38259337-C84B1D93-A7B8-4FAB-8131-A4014AE13EE8 Q38282842-63E5D17E-9542-4631-8028-52788A140FBD Q38287647-80F0F247-E372-495C-A677-47B7DA6DB8C6 Q38296021-DA8A9D90-73A5-49D1-BB18-D9E3B9FA4A7B Q38351487-3BE9212D-4446-41D7-AC7A-DBB5EAAFE851 Q38537772-7E5E2CAD-3726-4425-8F8C-5778A5C7B699 Q38669417-AADE8752-96EC-4154-9B37-96E1EFC517EB Q38680909-AC4B3056-021A-4940-810A-CF67DE1830F8 Q38682574-362762D8-D504-4E5F-8F2E-5FAD186709D2 Q38715316-AA876302-66C6-44AA-BD55-335CF80884C6 Q38764098-7CD256D2-3A8D-4AD5-832F-532B119A17C5 Q38786731-E9FEA6C3-817C-4164-8043-6EE95C339340

P2860

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

http://www.wikidata.org/entity/Q34373447

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@ast

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@en

Miravirsen

@nl

type

label

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@ast

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@en

Miravirsen

@nl

prefLabel

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@ast

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@en

Miravirsen

@nl

P1433

Q34373447-A717B63D-52F0-4A0E-9130-76E60C15C885

P1476

Q34373447-FEF4C74F-8098-4751-8D98-4544E2651AE4

P2093

Q34373447-01094D42-24E8-4DF0-9022-F97CE37290FB

Q34373447-B1123D3E-D970-456D-9FB8-AA2ADA9E8F60

Q34373447-CAF63155-2BA0-4472-AFC1-7B952AA1D950

Q34373447-FC9C7F4F-FC91-492A-A21F-8E0E111C9C33

Q34373447-FD79EC17-C366-4F58-A6F8-EC876472EB8C

P2860

Q34373447-0A229776-8CBE-4C43-AF4E-9D246E542337

Q34373447-0C6FB4C8-E343-40BB-8995-497C04C3D9B8

Q34373447-158FE023-ED74-45EC-B3A9-0A9275DB8DF1

Q34373447-1CD5C3CB-DB2C-4C7A-9841-717BD7E92542

Q34373447-245DDF8D-C39B-4CD8-84BC-778ACDA07ACE

Q34373447-287291CD-5DF8-41B0-9267-5C22E85C5550

Q34373447-28FB0FC1-AF0F-4ADC-9C0A-9FF7A46A67C9

Q34373447-2D0CB854-1787-48DE-A4D4-5790FAAF9014

Q34373447-2FF9236D-3321-47DF-99BB-60E03E0D279A

Q34373447-30155175-2F60-45BC-B98A-5E0E6E9F9224

P304

Q34373447-D96C37D1-29F0-4254-99EE-4ECC2C41982D

P31

Q34373447-DBDB3CBB-74D4-4254-989A-395F96D5DC65

P356

Q34373447-A56A5CAC-9ABA-424E-B773-065EF0DD36CA

P407

Q34373447-E2F485C9-DB67-4ACD-8791-B37A53549C1A

P433

Q34373447-482041FA-31A4-47BF-AF21-B25FE85D386D

P478

Q34373447-618088D1-6787-4194-AA7F-C6F224DBD7DF

P50

Q34373447-53B002F9-72CC-459F-8EB5-93850D5AB871

P577

Q34373447-92F62DB6-8303-4390-9C63-9B4C565408DE

P5875

Q34373447-9452DC90-90C6-4AA4-B4BC-181E3F41E7F4

P698

Q34373447-D107B405-B1B5-4C17-8513-D9728699C565

P932

Q34373447-A874A72F-1C29-41E2-8D69-2C2E72C85A5B

P356

P1433

Nucleic Acids Research

P1476

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

@en

P2093

Jonathan Hall

http://www.w3.org/2001/XMLSchema#string

Mario A E Rebhan

http://www.w3.org/2001/XMLSchema#string

Markus Stoffel

http://www.w3.org/2001/XMLSchema#string

Rémy Denzler

http://www.w3.org/2001/XMLSchema#string

Silvia E M Crivelli

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development

The nuclear RNase III Drosha initiates microRNA processing

The Microprocessor complex mediates the genesis of microRNAs

Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP

Improved targeting of miRNA with antisense oligonucleotides

miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay

Widespread regulatory activity of vertebrate microRNA* species

A mammalian microRNA expression atlas based on small RNA library sequencing

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

The impact of microRNAs on protein output

P304

609-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKT852

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Luca F R Gebert

P577

2013-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257074844

http://www.w3.org/2001/XMLSchema#string

P698

24068553

http://www.w3.org/2001/XMLSchema#string

P932

3874169

http://www.w3.org/2001/XMLSchema#string